These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35432201)

  • 1. Progranulin and Its Receptor Predict Kidney Function Decline in Patients With Type 2 Diabetes.
    Murakoshi M; Gohda T; Sakuma H; Shibata T; Adachi E; Kishida C; Ichikawa S; Koshida T; Kamei N; Suzuki Y
    Front Endocrinol (Lausanne); 2022; 13():849457. PubMed ID: 35432201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
    Kamei N; Yamashita M; Nishizaki Y; Yanagisawa N; Nojiri S; Tanaka K; Yamashita Y; Shibata T; Murakoshi M; Suzuki Y; Gohda T
    Sci Rep; 2018 Oct; 8(1):15302. PubMed ID: 30333553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies.
    Lang I; Füllsack S; Wajant H
    Front Immunol; 2018; 9():793. PubMed ID: 29740434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients.
    Gohda T; Murakoshi M; Suzuki Y; Hiki M; Naito T; Takahashi K; Tabe Y
    PLoS One; 2022; 17(10):e0275745. PubMed ID: 36219652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New discovery rarely runs smooth: an update on progranulin/TNFR interactions.
    Wang BC; Liu H; Talwar A; Jian J
    Protein Cell; 2015 Nov; 6(11):792-803. PubMed ID: 26408020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progranulin: a growth factor, a novel TNFR ligand and a drug target.
    Liu CJ; Bosch X
    Pharmacol Ther; 2012 Jan; 133(1):124-32. PubMed ID: 22008260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin promotes osteogenic differentiation of human periodontal ligament stem cells via tumor necrosis factor receptors to inhibit TNF-α sensitized NF-kB and activate ERK/JNK signaling.
    Chen J; Yu M; Li X; Sun QF; Yang CZ; Yang PS
    J Periodontal Res; 2020 Jun; 55(3):363-373. PubMed ID: 31854464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains.
    Jian J; Zhao S; Tian Q; Gonzalez-Gugel E; Mundra JJ; Uddin SM; Liu B; Richbourgh B; Brunetti R; Liu CJ
    FEBS Lett; 2013 Nov; 587(21):3428-36. PubMed ID: 24070898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells.
    Chen X; Chang J; Deng Q; Xu J; Nguyen TA; Martens LH; Cenik B; Taylor G; Hudson KF; Chung J; Yu K; Yu P; Herz J; Farese RV; Kukar T; Tansey MG
    J Neurosci; 2013 May; 33(21):9202-13. PubMed ID: 23699531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A solid-phase assay for studying direct binding of progranulin to TNFR and progranulin antagonism of TNF/TNFR interactions.
    Tian Q; Zhao S; Liu C
    Methods Mol Biol; 2014; 1155():163-72. PubMed ID: 24788181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic Hyperuricemia.
    Gohda T; Yanagisawa N; Murakoshi M; Ueda S; Nishizaki Y; Nojiri S; Ohashi Y; Ohno I; Shibagaki Y; Imai N; Iimuro S; Kuwabara M; Hayakawa H; Kimura K; Hosoya T; Suzuki Y
    Front Med (Lausanne); 2021; 8():634932. PubMed ID: 34322499
    [No Abstract]   [Full Text] [Related]  

  • 13. Progranulin promotes diabetic fracture healing in mice with type 1 diabetes.
    Wei J; Zhang L; Ding Y; Liu R; Guo Y; Hettinghouse A; Buza J; De La Croix J; Li X; Einhorn TA; Liu CJ
    Ann N Y Acad Sci; 2020 Jan; 1460(1):43-56. PubMed ID: 31423598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin promotes bone fracture healing via TNFR pathways in mice with type 2 diabetes mellitus.
    Ding Y; Wei J; Hettinghouse A; Li G; Li X; Einhorn TA; Liu CJ
    Ann N Y Acad Sci; 2021 Apr; 1490(1):77-89. PubMed ID: 33543485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.
    Tang W; Lu Y; Tian QY; Zhang Y; Guo FJ; Liu GY; Syed NM; Lai Y; Lin EA; Kong L; Su J; Yin F; Ding AH; Zanin-Zhorov A; Dustin ML; Tao J; Craft J; Yin Z; Feng JQ; Abramson SB; Yu XP; Liu CJ
    Science; 2011 Apr; 332(6028):478-84. PubMed ID: 21393509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling.
    Zhao YP; Tian QY; Frenkel S; Liu CJ
    Biomaterials; 2013 Sep; 34(27):6412-21. PubMed ID: 23746860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor necrosis factor-related biomarkers predict kidney function decline in Japanese patients with diabetes: An observational cohort study.
    Murakoshi M; Kamei N; Suzuki Y; Kubota M; Sanuki M; Tashiro H; Iwasawa T; Kato K; Tanaka M; Furuhashi M; Gohda T
    Diabetes Res Clin Pract; 2023 Dec; 206():111017. PubMed ID: 37972856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating TNF receptor levels are associated with estimated glomerular filtration rate even in healthy individuals with normal kidney function.
    Gohda T; Murakoshi M; Shibata T; Suzuki Y; Takemura H; Tsuchiya K; Okada T; Wakita M; Horiuchi Y; Tabe Y; Kamei N
    Sci Rep; 2024 Mar; 14(1):7245. PubMed ID: 38538662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three TNFR-binding domains of PGRN act independently in inhibition of TNF-alpha binding and activity.
    Tian Q; Zhao Y; Mundra JJ; Gonzalez-Gugel E; Jian J; Uddin SM; Liu C
    Front Biosci (Landmark Ed); 2014 Jun; 19(7):1176-85. PubMed ID: 24896343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
    Gohda T; Niewczas MA; Ficociello LH; Walker WH; Skupien J; Rosetti F; Cullere X; Johnson AC; Crabtree G; Smiles AM; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):516-24. PubMed ID: 22266664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.